Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients

Neuroscience Letters

Volumn 326, Issue 2, 2002, Pages 125-128

  Bahner, Dirk ^a   Klucke, Christine ^b   Kitze, Bernd ^b   Elitok, Ercan ^b   Bogumil, Timon ^c   Dressel, Alexander ^d   Tumani, Hayrettin ^e   Weber, Frank ^f   Poser, Sigrid ^b   Bitsch, Andreas ^g  

^a KLINIKUM FULDA   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c BAYER PHARMA AG   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^g Ruppiner Kliniken GmbH   (Germany)

Author keywords

Cytokines; Interferon beta 1b; Interleukin 12; Primary progressive multiple sclerosis

Indexed keywords

INTERFERON BETA SERINE; INTERLEUKIN 12; PROTEIN SUBUNIT;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; INTERFERON-BETA; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PROTEIN SUBUNITS; REFERENCE VALUES;

EID: 0037189067     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00311-7     Document Type: Article

References (20)

1. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy
2. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit
3. Serum interleukin-12 levels in patients with multiple sclerosis
4. Increased release of interleukin-12p40 in MS: Association with intracerebral inflammation
5. Cytokine production and surface marker expression in acute and stable multiple sclerosis: Altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis
6. Interleukin-12 is detectable in sera of patients with multiple sclerosis - Association with chronic progressive disease course?
7. Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing - Remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide
8. Interferon β-1b treatment in primary progressive multiple sclerosis-safety, evaluation of biological response, and assessment of progression measures
9. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
10. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer
11. Application of the poser criteria in primary progressive multiple sclerosis
12. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis
13. Impaired interleukin-12 production in multiple sclerosis patients
14. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat
15. Primary progressive multiple sclerosis
16. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis
17. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
18. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: Relevance to IFN-beta-1b therapeutic effects in multiple sclerosis
19. Expression of co stimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions
20. Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens